U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    SOCS6 suppressor of cytokine signaling 6 [ Homo sapiens (human) ]

    Gene ID: 9306, updated on 10-Dec-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Publisher Correction: MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.

    Publisher Correction: MiR-21 and miR-183 can simultaneously target SOCS6 and modulate growth and invasion of hepatocellular carcinoma (HCC) cells.
    Li ZB, Li ZZ, Li L, Chu HT, Jia M.

    07/22/2024
    Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways.

    Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways.
    Sun L, Ke M, Yin M, Zeng Y, Ji Y, Hu Y, Fu S, Zhang C., Free PMC Article

    01/31/2024
    Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.

    Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S, Lu X, Zheng D, Chen W, Li Y, Li F.

    10/29/2022
    MicroRNA-494-3p Exacerbates Renal Epithelial Cell Dysfunction by Targeting SOCS6 under High Glucose Treatment.

    MicroRNA-494-3p Exacerbates Renal Epithelial Cell Dysfunction by Targeting SOCS6 under High Glucose Treatment.
    Xue X, Liu M, Wang Y, Yang Y, Li Z, Shi R, Miao Y.

    04/16/2022
    Down-regulation of SOCS6: an unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis.

    Down-regulation of SOCS6: an unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis.
    Ouyang J, An T, Wang Y, Lu X, Zhang Y, Wang X, Zhang X, Zhang C., Free PMC Article

    03/19/2022
    Circ_0085289 Alleviates the Progression of Periodontitis by Regulating let-7f-5p/SOCS6 Pathway.

    Circ_0085289 Alleviates the Progression of Periodontitis by Regulating let-7f-5p/SOCS6 Pathway.
    Du W, Wang L, Liao Z, Wang J.

    12/25/2021
    Circular RNA circ_103820 suppresses lung cancer tumorigenesis by sponging miR-200b-3p to release LATS2 and SOCS6.

    Circular RNA circ_103820 suppresses lung cancer tumorigenesis by sponging miR-200b-3p to release LATS2 and SOCS6.
    Chi Y, Zheng W, Bao G, Wu L, He X, Gan R, Shen Y, Yin X, Jin M., Free PMC Article

    09/25/2021
    Inhibition of miR-1298-5p attenuates sepsis lung injury by targeting SOCS6.

    Inhibition of miR-1298-5p attenuates sepsis lung injury by targeting SOCS6.
    Ma J, Xu LY, Sun QH, Wan XY, BingLi.

    09/4/2021
    Inhibition of SOCS6 confers radioresistance in esophageal squamous cell carcinoma.

    Inhibition of SOCS6 confers radioresistance in esophageal squamous cell carcinoma.
    Ma R, Shi M, Hu J, Zhao LN.

    06/26/2021
    miR-155-5p Implicates in the Pathogenesis of Renal Fibrosis via Targeting SOCS1 and SOCS6.

    miR-155-5p Implicates in the Pathogenesis of Renal Fibrosis via Targeting SOCS1 and SOCS6.
    Zhang W, Li X, Tang Y, Chen C, Jing R, Liu T., Free PMC Article

    02/6/2021
    microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6.

    microRNA-454 promotes liver tumor-initiating cell expansion by regulating SOCS6.
    Lei Z, Tang X, Si A, Yang P, Wang L, Luo T, Guo G, Zhang Q, Cheng Z.

    12/12/2020
    Study is the first to illustrate that miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate NSCLC cell proliferation and apoptosis, and is a potential biomarker and therapeutic target for NSCLC.

    miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC.
    Xia Y, Wei K, Yang FM, Hu LQ, Pan CF, Pan XL, Wu WB, Wang J, Wen W, He ZC, Xu J, Xu XF, Zhu Q, Chen L., Free PMC Article

    06/6/2020
    FGD5-AS1/miR-142-3p/SOCS6 axis may act as an important indicator

    Abnormal expression of long noncoding RNA FGD5-AS1 affects the development of periodontitis through regulating miR-142-3p/SOCS6/NF-κB pathway.
    Chen H, Lan Z, Li Q, Li Y.

    11/23/2019
    Low SOCS6 expression is associated with Prostate Cancer.

    SOCS6 Functions as a Tumor Suppressor by Inducing Apoptosis and Inhibiting Angiogenesis in Human Prostate Cancer.
    Yuan D, Wang W, Su J, Zhang Y, Luan B, Rao H, Cheng T, Zhang W, Xiao S, Zhang M, Jiang FN, Sun Z, Jia Z, Zhong WD, Zhu J.

    10/5/2019
    Together, our data provide important evidence for miR-19 mediated SOCS6 in OS growth and revealed miR-19/SOCS6/JAK2/STAT3 pathway as a potential therapeutic strategy for OS patients.

    miR-19 promotes osteosarcoma progression by targeting SOCS6.
    Sun Z, Liu Q, Hong H, Zhang H, Zhang T.

    12/30/2017
    Results indicate that similar to PTEN pseudogene (PTENP1), suppressor of cytokine signaling 6 protein (SOCS6) expression was also significantly lower in esophageal squamous cell carcinoma (ESCC) samples.

    PTENP1 inhibits the growth of esophageal squamous cell carcinoma by regulating SOCS6 expression and correlates with disease prognosis.
    Gong T, Zheng S, Huang S, Fu S, Zhang X, Pan S, Yang T, Sun Y, Wang Y, Hui B, Guo J, Zhang X., Free PMC Article

    12/9/2017
    our results describe for the first time the role of miR-494-3p during normal hematopoietic stem/progenitor cells differentiation and suggest that its increased expression, and the subsequent downregulation of its target SOCS6, might contribute to the megakaryocyte hyperplasia commonly observed in primary myelofibrosis patients.

    miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6.
    Rontauroli S, Norfo R, Pennucci V, Zini R, Ruberti S, Bianchi E, Salati S, Prudente Z, Rossi C, Rosti V, Guglielmelli P, Barosi G, Vannucchi A, Tagliafico E, Manfredini R., Free PMC Article

    10/14/2017
    miR-142-3p regulates NPC development by down-regulating SOCS6 expression and suggest that modulation of miR-142-3p expression could be a therapeutic strategy for NPC

    MiR-142-3p Suppresses SOCS6 Expression and Promotes Cell Proliferation in Nasopharyngeal Carcinoma.
    Qi X, Li J, Zhou C, Lv C, Tian M.

    05/21/2016
    Stage-independent downregulation of SOCS2 and SOCS6 correlate with disease-free survival in colorectal cancer.

    Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer.
    Letellier E, Schmitz M, Baig K, Beaume N, Schwartz C, Frasquilho S, Antunes L, Marcon N, Nazarov PV, Vallar L, Even J, Haan S., Free PMC Article

    10/11/2014
    Studied both the function of upregulated miR-424-5p in pancreatic cancer and how downstream suppressor of cytokine-induced signaling 6 (SOCS6) is negatively regulated by miR-424-5p.

    MicroRNA-424-5p suppresses the expression of SOCS6 in pancreatic cancer.
    Wu K, Hu G, He X, Zhou P, Li J, He B, Sun W.

    10/4/2014
    miR-17-5p might function as a pro-proliferative factor by repressing SOCS6 in gastric cancer

    miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells.
    Wu Q, Luo G, Yang Z, Zhu F, An Y, Shi Y, Fan D.

    07/19/2014
    SOCS2 and SOCS6 expression are remarkably reduced in hepatocellular carcinoma and correlate with aggressive tumor progression and poor prognosis

    Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis.
    Qiu X, Zheng J, Guo X, Gao X, Liu H, Tu Y, Zhang Y.

    11/16/2013
    Results show that SOCS6 forms complex with DRP1 and the mitochondrial phosphatase PGAM5, attenuates DRP1 phosphorylation, and promotes DRP1 mitochondrial translocation.

    Suppressor of cytokine signaling 6 (SOCS6) promotes mitochondrial fission via regulating DRP1 translocation.
    Lin HY, Lai RH, Lin ST, Lin RC, Wang MJ, Lin CC, Lee HC, Wang FF, Chen JY., Free PMC Article

    08/31/2013
    SOCS6 negatively regulates Flt3 activation, the downstream Erk signaling pathway, and cell proliferation.

    Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3.
    Kazi JU, Sun J, Phung B, Zadjali F, Flores-Morales A, Rönnstrand L., Free PMC Article

    12/29/2012
    Reduced copy number and mRNA expression of SOCS6 are associated with disease recurrence in primary lung squamous cell carcinoma and may be useful prognostic biomarkers.

    Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma.
    Sriram KB, Larsen JE, Savarimuthu Francis SM, Wright CM, Clarke BE, Duhig EE, Brown KM, Hayward NK, Yang IA, Bowman RV, Fong KM., Free PMC Article

    06/30/2012
    firstprevious page of 2 nextlast